Optiver Holding
NVAX icon

Optiver Holding’s Novavax NVAX Stock Holding History

Optiver Holding’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,413
Closed -$19.6K – 2996
2026
Q1 		$19.6K Buy
2,413
+2,177
+922% +$19.7K ﹤0.01% 1103
2025
Q4 		$1.59K Sell
236
-958
-80% -$7.22K ﹤0.01% 2109
2025
Q3 		$10.4K Buy
1,194
+614
+106% +$4.78K ﹤0.01% 1284
2025
Q2 		$3.65K Buy
580
+6
+1% +$40 ﹤0.01% 1265
2025
Q1 		$3.68K Buy
574
+121
+27% +$1K ﹤0.01% 1152
2024
Q4 		$3.64K Sell
453
-6,860
-94% -$66.1K ﹤0.01% 898
2024
Q3 		$92.4K Buy
+7,313
New +$94.4K ﹤0.01% 516

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Optiver Holding's NVAX Position: Q2 2026 in Review

Optiver Holding sold out of Novavax (NVAX) in Q2 2026, closing a stake of 2,413 shares — an estimated $19.6K sold.

Optiver Holding first reported a position in NVAX in Q3 2024 and held it in 7 quarters. The position peaked at $92.4K in Q3 2024. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Optiver Holding reported no remaining Novavax position as of Q2 2026 after selling out during the quarter.
  • Optiver Holding sold 2,413 Novavax shares in Q2 2026, an estimated $19.6K.
  • Optiver Holding first reported a position in Novavax in Q3 2024 and held it in 7 quarters.
  • Optiver Holding's Novavax position peaked at $92.4K in Q3 2024.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.